Bell John Irving 4
4 · Immunocore Holdings plc · Filed May 19, 2025
Insider Transaction Report
Form 4
Bell John Irving
Director
Transactions
- Award
Share Option (Right to Buy)
2025-05-15+26,198→ 26,198 totalExercise: $29.06Exp: 2035-05-14→ Ordinary Shares (26,198 underlying)
Footnotes (1)
- [F1]The shares subject to the option award shall vest at the earlier of (i) May 15, 2026 and (ii) the day immediately prior to the date of our next annual general meeting, subject to the Reporting Person's continuous service through such vesting date.